Pertussis historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The first evidence of Pertussis occurrences | The first evidence of Pertussis occurrences date back to the 12th century, based on reporting of symptoms of the disease. The first recognized outbreaks of Pertussis were in 1502 in Persia by Bahaodwole Razi, followed by the 1578 outbreak in France as recognized by Guillaume de Baillou. [[Bordetella pertussis]], the causative organism, was discovered by Jules Bordet and Octave Gengou in 1906. Bordet and Gengou developed the first vaccine and serological test for Pertussis. In the 1940s, Pertussis vaccinations were combined with diptheria and tetanus toxoids to develop the first combinaton DTP vaccine, created by Grace Elderling, Loney Gordon, and Pearl Kendrick. In response to adverse side effects of DTP, a safer, acellular vaccine was created in Japan in 1981 and was incorporated into the The DTaP combination vaccine in 1992 for widespread use. | ||
==Historical Perspective== | ==Historical Perspective== | ||
Revision as of 18:05, 5 January 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
|
Pertussis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pertussis historical perspective On the Web |
|
American Roentgen Ray Society Images of Pertussis historical perspective |
|
Risk calculators and risk factors for Pertussis historical perspective |
Overview
The first evidence of Pertussis occurrences date back to the 12th century, based on reporting of symptoms of the disease. The first recognized outbreaks of Pertussis were in 1502 in Persia by Bahaodwole Razi, followed by the 1578 outbreak in France as recognized by Guillaume de Baillou. Bordetella pertussis, the causative organism, was discovered by Jules Bordet and Octave Gengou in 1906. Bordet and Gengou developed the first vaccine and serological test for Pertussis. In the 1940s, Pertussis vaccinations were combined with diptheria and tetanus toxoids to develop the first combinaton DTP vaccine, created by Grace Elderling, Loney Gordon, and Pearl Kendrick. In response to adverse side effects of DTP, a safer, acellular vaccine was created in Japan in 1981 and was incorporated into the The DTaP combination vaccine in 1992 for widespread use.
Historical Perspective
Discovery
- The earliest evidence of people displaying symptoms of Pertussis occurred during the Middle Ages in the 12th century, described as "the kink" or "the kindhoest" in Scotland to indicate a cough or fit.[1]
- The first offically recognized outbreak of Pertussis was in 1502 in the former Persian Empire, recorded by Persian Physician Bahaodowle Razi.[2]
- Pertussis was first officially recognized in Europe by French physician Guillaume de Baillou in 1578 during its outbreak in Paris.[1].
- The causative organism, Bordetella pertussis, was discovered and isolated in 1906 by Belgian biologists Jules Bordet and Octave Gengou.
Development of Treatment Strategies
- Jules Bordet and Octave Gengou developed the first vaccine and serological test for Pertussis following discovery of Bordetella pertussis.
- In 1942, American scientists Grace Eldering, Loney Gordon, and Pearl Kendrick combined the whole-cell pertussis vaccine with diphtheria and tetanus toxoids to generate the first DTP combination vaccine.
- In 1981 an acelluar vaccine was created in Japan and was added, in 1992, to the DTP Vaccine to create the DTaP vaccine, which had a much smaller rate of adverse side effects.[3]
References
- ↑ 1.0 1.1 Cherry, James D. (November 1996). "Historical Review of Pertussis and the Classical Vaccine" (PDF). Journal of Infectious Diseases. Oxford. 174 (3): 259–263. Retrieved 5 January 2016.
- ↑ Yarmohammadi H, Bahmani Kazeruni MH, Soofi A, Zargaran A (2015). "The First Report of Epidemic Pertussis by Bahaodowle Razi From the 15th Century Anno Domini". Iran Red Crescent Med J. 17 (7): e13454. doi:10.5812/ircmj.13454. PMC 4580069. PMID 26413316.
- ↑ Pichichero ME, Rennels MB, Edwards KM, Blatter MM, Marshall GS, Bologa M; et al. (2005). "Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults". JAMA. 293 (24): 3003–11. doi:10.1001/jama.293.24.3003. PMID 15933223. Review in: Evid Based Med. 2006 Apr;11(2):51